- $110.30m
- $130.59m
- $104.67m
- 46
- 87
- 28
- 53
Annual income statement for Emeren, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 8-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 119 | 73.5 | 79.7 | 61.3 | 105 |
Cost of Revenue | |||||
Gross Profit | 34.2 | 16.7 | 31.4 | 15.3 | 23.3 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 120 | 66.7 | 67 | 63.9 | 113 |
Operating Profit | -0.964 | 6.78 | 12.7 | -2.63 | -8.06 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.6 | 2.32 | 7.39 | -2.63 | -9.21 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.7 | 2.16 | 6.61 | -4.55 | -11.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -8.83 | 2.78 | 6.86 | -4.67 | -9.32 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.83 | 2.78 | 6.86 | -4.67 | -9.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.006 | 0.008 | 0.012 | -0.007 | -0.014 |